Yanxia Liu

613 total citations
19 papers, 499 citations indexed

About

Yanxia Liu is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Yanxia Liu has authored 19 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Immunology. Recurrent topics in Yanxia Liu's work include Autophagy in Disease and Therapy (3 papers), RNA modifications and cancer (3 papers) and Cancer-related gene regulation (3 papers). Yanxia Liu is often cited by papers focused on Autophagy in Disease and Therapy (3 papers), RNA modifications and cancer (3 papers) and Cancer-related gene regulation (3 papers). Yanxia Liu collaborates with scholars based in China, United States and Australia. Yanxia Liu's co-authors include Chenghui Yan, Xiaoxiang Tian, Yaling Han, Meili Liu, Dan Liu, Xiaoyan Zhang, Yang Wang, Xiaoying Shen, Xi-Mei Chen and Hengjun Gao and has published in prestigious journals such as PLoS ONE, Development and Hepatology.

In The Last Decade

Yanxia Liu

19 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanxia Liu China 15 318 106 95 54 52 19 499
Shuya Zhang China 12 304 1.0× 62 0.6× 59 0.6× 32 0.6× 39 0.8× 21 594
Hao Feng China 14 296 0.9× 74 0.7× 51 0.5× 47 0.9× 47 0.9× 49 524
E Liong Hong Kong 11 177 0.6× 59 0.6× 83 0.9× 37 0.7× 28 0.5× 15 429
Wang‐Xiang Xu China 12 475 1.5× 111 1.0× 122 1.3× 46 0.9× 26 0.5× 23 755
Nirmala Tilija Pun South Korea 13 212 0.7× 114 1.1× 165 1.7× 45 0.8× 19 0.4× 15 439
V. Vallet France 13 296 0.9× 69 0.7× 47 0.5× 40 0.7× 86 1.7× 17 582
Luguo Sun China 12 228 0.7× 43 0.4× 44 0.5× 39 0.7× 38 0.7× 16 372
Aijing Sun China 13 387 1.2× 78 0.7× 53 0.6× 17 0.3× 50 1.0× 34 613

Countries citing papers authored by Yanxia Liu

Since Specialization
Citations

This map shows the geographic impact of Yanxia Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanxia Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanxia Liu more than expected).

Fields of papers citing papers by Yanxia Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanxia Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanxia Liu. The network helps show where Yanxia Liu may publish in the future.

Co-authorship network of co-authors of Yanxia Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanxia Liu. A scholar is included among the top collaborators of Yanxia Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanxia Liu. Yanxia Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Liu, Dan, Xiaoxiang Tian, Yanxia Liu, et al.. (2021). CREG ameliorates the phenotypic switching of cardiac fibroblasts after myocardial infarction via modulation of CDC42. Cell Death and Disease. 12(4). 355–355. 10 indexed citations
2.
Song, Haixu, Xiaoxiang Tian, Dan Liu, et al.. (2021). CREG1 improves the capacity of the skeletal muscle response to exercise endurance via modulation of mitophagy. Autophagy. 17(12). 4102–4118. 29 indexed citations
3.
Liu, Yanxia, Xiaoxiang Tian, Shan Liu, et al.. (2020). DNA hypermethylation: A novel mechanism of CREG gene suppression and atherosclerogenic endothelial dysfunction. Redox Biology. 32. 101444–101444. 35 indexed citations
4.
Liu, Dan, Yu Cao, Xiaolin Zhang, et al.. (2018). Chemokine CC-motif ligand 2 participates in platelet function and arterial thrombosis by regulating PKCα-P38MAPK-HSP27 pathway. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(9). 2901–2912. 19 indexed citations
5.
Tian, Xiaoxiang, Chenghui Yan, Meili Liu, et al.. (2017). CREG1 heterozygous mice are susceptible to high fat diet-induced obesity and insulin resistance. PLoS ONE. 12(5). e0176873–e0176873. 20 indexed citations
6.
Zhao, Ling‐Ping, Xiaoxiang Tian, Chenghui Yan, et al.. (2017). The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance. Hepatology. 66(3). 834–854. 34 indexed citations
7.
Li, Yang, Yanxia Liu, Xiaoxiang Tian, et al.. (2017). Cellular Repressor of E1A-Stimulated Genes Is a Critical Determinant of Vascular Remodeling in Response to Angiotensin II. Arteriosclerosis Thrombosis and Vascular Biology. 37(3). 485–494. 15 indexed citations
8.
Song, Haixu, Chenghui Yan, Xiaoxiang Tian, et al.. (2016). CREG protects from myocardial ischemia/reperfusion injury by regulating myocardial autophagy and apoptosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(8). 1893–1903. 54 indexed citations
9.
Liu, Yanxia, Xiaoxiang Tian, Dan Liu, et al.. (2016). Up-Regulation of CREG Expression by the Transcription Factor GATA1 Inhibits High Glucose- and High Palmitate-Induced Apoptosis in Human Umbilical Vein Endothelial Cells. PLoS ONE. 11(5). e0154861–e0154861. 15 indexed citations
10.
Sun, Mingyu, Xiaoxiang Tian, Yanxia Liu, et al.. (2015). Cellular repressor of E1A-stimulated genes inhibits inflammation to decrease atherosclerosis in ApoE−/− mice. Journal of Molecular and Cellular Cardiology. 86. 32–41. 10 indexed citations
11.
Zhang, Feng, Xutao Zhang, Jin Meng, et al.. (2015). ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer. Oncotarget. 6(18). 16239–16252. 30 indexed citations
12.
Salvador, Lilibeth A., Jason C. Kwan, Qi-Yin Chen, et al.. (2014). Evaluation of class I HDAC isoform selectivity of largazole analogues. Bioorganic & Medicinal Chemistry Letters. 24(16). 3728–3731. 30 indexed citations
13.
Wang, Shaoxun, Qi Zhang, Man Shang, et al.. (2014). Microvesicles derived from hypoxia/reoxygenation-treated human umbilical vein endothelial cells impair relaxation of rat thoracic aortic rings.. PubMed. 30(6). 560–6. 4 indexed citations
14.
Xue-lin, Zhang, Chengzhi He, Baofu Chen, et al.. (2013). Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma. Pathology - Research and Practice. 209(8). 510–515. 53 indexed citations
15.
Wang, Yang, Yanxia Liu, Xiaoying Shen, et al.. (2012). The PIWI protein acts as a predictive marker for human gastric cancer.. PubMed. 5(4). 315–25. 75 indexed citations
16.
Huang, Xianqing, Miaoyun Li, Gaiming Zhao, et al.. (2012). Optimization on Antimicrobial Effects of Natural Compound Preservative Against B. cereus and E. coli by RSM. International Journal of Peptide Research and Therapeutics. 18(4). 383–389. 5 indexed citations
17.
Lv, Yuanyuan, Yue Jin, Guozhu Han, et al.. (2011). Ursolic acid suppresses IL-6 induced C-reactive protein expression in HepG2 and protects HUVECs from injury induced by CRP. European Journal of Pharmaceutical Sciences. 45(1-2). 190–194. 20 indexed citations
18.
Liu, Yanxia, Guozhu Han, Peng Liu, et al.. (2011). Protective effect of α -lipoic acid on oxidized low density lipoprotein-induced human umbilical vein endothelial cell injury. Pharmacological Reports. 63(5). 1180–1188. 20 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuya Zhang Breakdown of academic impact, for papers by Hao Feng Breakdown of academic impact, for papers by E Liong Breakdown of academic impact, for papers by Wang‐Xiang Xu Breakdown of academic impact, for papers by Nirmala Tilija Pun Breakdown of academic impact, for papers by V. Vallet Breakdown of academic impact, for papers by Luguo Sun Breakdown of academic impact, for papers by Aijing Sun
Rankless by CCL
2026